Focal adhesion kinase and its potential involvement in tumor invasion and metastasis

Head and Neck

Volumn 20, Issue 8, 1998, Pages 745-752

  Kornberg, Lori J ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Focal adhesion kinase; Metastasis; Tumor invasion

Indexed keywords

FOCAL ADHESION KINASE;

ANGIOGENESIS; ANIMAL CELL; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; DISEASE MARKER; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH;

ANIMALS; CELL ADHESION MOLECULES; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; INTEGRINS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION;

EID: 0031657454     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(199812)20:8<745::AID-HED14>3.0.CO;2-Z     Document Type: Review

References (52)

1. Hunter T, Cooper JA. Protein-tyrosine kinases. Ann Rev Biochem 1985;54:897-930.
2. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 1991;252: 668-674.
3. Albeda SM, Buck CA. Integrins and other cell adhesion molecules. Faseb J 1990;4:2868-2880.
4. Rosales C, O'Brien V, Kornberg LJ, Juliano RL. Signal transduction by cell adhesion receptors. Biochim Biophys Acta 1995;1242:77-97.
5. Juliano RL, Varner JA. Adhesion molecules in cancer: the role of integrins. Curr Opin Cell Biol 1993;5:812-818.
6. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124: 619-626.
7. Burridge K, Fath K, Kelly T, Nuckolls G, Turner C. Focal adhesion transmembrane junctions between the extracellular matrix and cytoskeleton. Ann Rev Cell Biol 1988;4: 487-525.
8. Kanner SB, Reynolds AB, Vines RR, Parson JT. Monoclonal antibodies to individual tyrosine phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 1992;182:5192-5196.
9. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT. Pp125FAK: A structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 1992;89:5192-5196.
10. Hanks SK, Calalb MB, Harper MC, Patel SK. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Nat Acad Sci USA 1992;89:8487-8491.
11. Kornberg LJ, Earp HS, Parsons JT, Schaller M, Juliano RL. Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem 1992;267:23439-23442.
12. Zachary I, Rozengurt E. Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 1992;71:891-894.
13. Matsumato K, Matsumato K, Nakamura T ,Kramer R. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1995;269:31807-31813.
14. Pillay TS, Sasaoka T, Olefsky JM. Insulin stimulates the tyrosine dephosphorylation of pp125 focal adhesion kinase. J Biol Chem 1995;270:991-994.
15. Turner CE, Schaller MD, Parsons JT. Tyrosine phosphorylation of the focal adhesion kinase pp125FAK during development: relation to paxillin. J Cell Sci 1993;105: 637-645.
16. Polte TR, Naftilan AJ, Hanks SK. Focal adhesion kinase is abundant in developing blood vessels and evaluation of its phosphotyrosine content in vascular smooth muscle cells is a rapid response to angiotensin II. J Cell Biochem 1994;55:106-119.
17. Andre E, Becker-Andre. N-Terminal truncated form of human focal adhesion kinase in brain. Biochem Biophys Res Commun 1993;190:140-147.
18. Berry V, Rathod H, Pulman LB, Datta HK. Immunofluorescent evidence for the abundance of focal adhesion kinase in the human and the avian osteoclasts and its down regulation by calcitonin. J Endocrinol 1994;141:R11-R15.
19. Schaller MD, Otey CA, Hildebrand JD, Parsons JT. Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol 1995;130: 1181-1187.
20. Polte TR, Hanks SK. Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proc Natl Acad Sci USA 1995;92:10678-10682.
21. Hildebrand JD, Schaller MD, Parsons JT. Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol 1993;123:993-1005.
22. Schaller MD, Borgman CA, Parsons JT. Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell Biol 1993;13:785-791.
23. Richardson A, Parsons T. A mechanism for regulation of the adhesion-associated protein tyrosine kinase pp125FAK. Nature 1996;380:538-540.
24. Richardson A, Parsons JT. Signal transduction through integrins: a central role for focal adhesion kinase?. Bioessays 1996;17:229-236.
25. Schaller MD, Hildebrand JD, Shannon JD, Fox JW, Vines RR, Parsons JT. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 1994;14:1680-1688.
26. Calalb MB, Polte TR, Hanks SK. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995;15:954-963.
27. Schlaepfer DD, Hanks SK, Hunter T, van der Geer P. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature 1994;372:786-791.
28. Schlaepfer DD, Hunter T. Evidence for in vivo phosphorylation of the GRB2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol Cell Biol 1996;16:5623-5633.
29. Lin TL, Aplin AE, Shen Y, et al. Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J Cell Biol 1997;136:1385-1395.
30. Hildebrand JD, Schaller MD, Parsons JT. Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell 1995;6:637-647.
31. Schaller MD, Parsons JT. pp125FAK-Dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell Biol 1995;15:2635-2645.
32. Bachelot C, Rameh L, Parsons T, Cantley LC. Association of phosphatidylinositol 3-kinase, via the SH2 domains of p85, with focal adhesion kinase in polyoma middle t-transformed fibroblasts. Biochim Biophys Acta 1996; 1311:45-52.
33. Chen HC, Appeddu PA, Parsons JT, Hildebrand JD, Schaller MD, Guan JL. Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem 1995; 270:16995-16999.
34. Frisch SM, Vuori K, Ruoslahti E, Chan Hui PY. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 1996;134:793-799.
35. Crouch DH, Fincham VJ, Frame MC. Targeted proteolysis of the focal adhesion kinase pp125FAK during c-MYC induced apoptosis is suppressed by integrin signalling. Oncogene 1996;12:2689-2696.
36. Xu LH, Owens LV, Sturge GC, et al. Attenuation of expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 1996;7:413-418.
37. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, Otey CA. Inhibition of pp125FAK in cultured fibroblast results in apoptosis. J Cell Biol 1996;135:1383-1390.
38. Gates RE, King LE, Hanks SK, Nanney LB. Potential role for focal adhesion kinase in migrating and proliferating keratinocytes near epidermal wounds and in culture. Cell Growth Differ 1994:891-899.
39. Akasaka T, van Leeuwen RL, Yoshinoga IG, Mihm MC Jr, Byers HR. Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines. J Invest Dermatol 1995;105:104-108.
40. Ilic D, Furuta Y, Kanasawa S, et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995;377:539-544.
41. Furuta Y, Ilic D, Kanazawa S, Takeda N, Yamamoto T, Aizawa S. Mesodermal defect in late phase of gastrulation by a targeted mutation of focal adhesion kinase, FAK. Oncogene 1995;11:1989-1995.
42. Ilic D, Kanasawa S, Furuta Y, Yamamoto T, Aizawa S. Impairment of mobility in endodermal cells by FAK deficiency. Exp Cell Res 1996;222:298-303.
43. Gary LA, Chang JF, Guan JL. Stimulation of cell migration by over expression of focal adhesion kinase and its association with Src and Fyn. J Cell Sci 1996;109: 1787-1794.
44. Gilmore AP, Romer LH. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 1996;7:1209-1224.
45. Weiner TM, Liu ET, Craven RJ, Cance WG. Expression of focal adhesion kinase gene in invasive cancer. Lancet. 1993;342:1024-1025.
46. Owens LV, Xu L, Craven RJ, et al. Over expression of the focal adhesion kinase (p125FAK) in invasive human tumors. Cancer Res 1995;55:2752-2755.
47. Glukhova M, Koteliansky V, Sastre X, Thiery JP. Adhesion systems in normal breast and in invasive breast carcinoma. Am J Pathol 1995;146:706-716.
48. Owens LV, Xu L, Dent GA, et al. Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 1996;3:100-105.
49. Tremblay L, Haule W, Aprikia AG, Begin LR, Chapdelaine A, Chevelier S. Focal adhesion kinase (pp125FAK) expression, activation, and association with paxillin and p50 csk in human metastatic prostate carcinoma. Int J Cancer 1996;68:164-171.
50. Han NM, Fleming RY, Curley SA, Gallick GE. Over expression of focal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann Surg Oncol 1997;4:264-268.
51. McCormack SJ, Brazinski SE, Moore JL Jr, Werness BA, Goldstein DJ. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 1997;15:265-274.
52. Kornberg LJ. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 1998;20:745-752.